1-5 of 5
Hedwig M Blommestein
Close
Sort by
Journal Articles

Cost-effectiveness: maximizing impact by meticulous data

Clinical Trials & Observations
Hedwig M. Blommestein, Sonja Zweegman
Journal: Blood
Blood (2022) 140 (6): 525–526.
https://doi.org/10.1182/blood.2022016958
Published: 2022
Journal Articles

One Line Does Not Make a Picture: Real-World Cost-Effectiveness Of Multiple Myeloma Treatments Using a Full Disease Model

Hedwig M Blommestein, Silvia GR Verelst, Saskia de Groot, Peter C. Huijgens, MD, PhD, Pieter Sonneveld, MD, Ph.D, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2013) 122 (21): 2930.
https://doi.org/10.1182/blood.V122.21.2930.2930
Published: 2013
Journal Articles

Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study

Hedwig M Blommestein, Djamila E Issa, MD, Marjolein Pompen, PhD, Cédric Révil, Mels Hoogendoorn, MD, PhD, Peter Joosten, MD, Sonja Zweegman, MD, PhD, Peter C. Huijgens, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4277.
https://doi.org/10.1182/blood.V120.21.4277.4277
Published: 2012
Journal Articles

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Hedwig M Blommestein, Silvia GR Verelst, Jan J Cornelissen, MD, PhD, Peter C Huijgens, MD, PhD, Nicole MA Blijlevens, MD, PhD, Carin A Uyl-de Groot, PhD
Journal: Blood
Blood (2011) 118 (21): 2079.
https://doi.org/10.1182/blood.V118.21.2079.2079
Published: 2011
Journal Articles

Trends in Incidence and Survival of Multiple Myeloma in the Netherlands in the Last Two Decades. Results From a National Population Based Study

Silvia GR Verelst, Hedwig M Blommestein, Henrike E Karim-Kos, Peter C Huijgens, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 5071.
https://doi.org/10.1182/blood.V118.21.5071.5071
Published: 2011